Orexigen Therapeutics (OREX)
News
| 10:24AM | 3 Health-Care Stocks Crushing the Market Fool |
| May 25 | 4 Smaller Alternatives to Big Pharma Obesity Treatments Benzinga |
| May 24 | A Ticket to Ride from AdComm to PDUFA Fool |
| May 21 | $ARNA rebounds after share offering last week at $5.50 $OREX $VVUS http://stks.co/3vPY by EPS_MomentuM |
| May 21 | $SD close up 6.91% $SIRI close up 5.32% $DANG close up 4.04% $VE close up 3.63% $RWC close up 3.45% $OREX close up2.62% $XOMA close up 2.11% by DrNick |
| May 21 | $OREX UP 1.75% $CLWR UP 3% by DrNick |
| May 16 | RT @CAPMrules: $ARNA $ VVUS $OREX buy em all. Hold long term. DO NOT DAY TRADE. < finally! You can only lose money by day trading!!! > by Caesar |
| May 15 | $ARNA $ VVUS $OREX buy em all. Hold long term. DO NOT DAY TRADE. by CAPMrules |
| May 15 | RT @Bleedblue: RT @newkidontheblock FDA follows Adcom rec 80 percent. $orex anyone? Was the 20% it DOES happen. by DutchFanBoy |
| May 15 | FDA Approval Sends this Biopharma Company Soaring 74% Fool |
| May 14 | VIVUS Is A Viable Long Term Investment |
Profile
Exchange: NASDAQGM Sector: Healthcare Industry: Drug Manufacturers - Other
1 Year Total Return Performance
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Orexigen Therapeutics is up 17.67% over the last year vs S&P 500 Total Return up 2.03%, Arena Pharmaceuticals up 308.2%, and Vivus up 180.4%.
- OREX Total Returns
- ^SPXTR Total Returns
- ARNA Total Returns
- VVUS Total Returns
Fundamentals
Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.
Cash Flow Statement View Statement
You may also be interested in these OREX related companies
Pro Strategies Featuring OREX
Did Orexigen Therapeutics make it into our Pro Portfolio Strategies?
OREX Charts
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Other OREX Resources
- Investor Relations
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership MSN Money
- SEC Filings SEC
- Technical Charts Chart.ly
- Trading Ideas Benzinga
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| OREX | 3.33 | -0.10 | -2.92% | 225.57M |
| ORCL | 26.14 | +0.02 | +0.08% | 131.38B |
| OPTR | 15.32 | -0.28 | -1.79% | 716.21M |
| OMG | 18.10 | +0.18 | +1.00% | 585.17M |
| OMEX | 3.33 | +0.14 | +4.39% | 243.56M |
| OMCL | 13.71 | -0.06 | -0.44% | 459.15M |
| OMC | 49.78 | -0.32 | -0.64% | 13.58B |
| OLP | 18.56 | -0.26 | -1.38% | 273.39M |
| OLCB | 1.10 | +0.09 | +8.91% | 21.69M |
| OIB | 7.81 | +0.03 | +0.45% |
